Prescription Drug Monitoring Act of 2017

Summary

Prescription Drug Monitoring Act of 2017 This bill requires a state that receives grant funds under the prescription drug monitoring program (PDMP) or the controlled substance monitoring program to comply with specified requirements, including a requirement to share its PDMP data with other states. The Department of Justice (DOJ) or Department of Health and Human Services may withhold grant funds from a state that fails to comply. To facilitate data sharing among states, the bill directs DOJ to award a grant under the Comprehensive Opioid Abuse Grant Program to establish and maintain a data-sharing hub.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 3 April 2017

   Introduced

   Introduced in House

   Source: IntroReferral

2. 3 April 2017

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 3 April 2017

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

4. 3 April 2017

   Introduced

   Introduced in House

   Source: IntroReferral

5. 7 April 2017

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

6. 24 April 2017

   Referred

   Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 3 April 2017 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 3 April 2017

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 3 April 2017

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 3 April 2017

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Jenkins, Evan H. [R-WV-3] · R · Sponsor
• Rep. Ryan, Tim [D-OH-13] · D · Sponsor
• Rep. Donovan, Daniel M., Jr. [R-NY-11] · R · Cosponsor
• Rep. Comstock, Barbara [R-VA-10] · R · Cosponsor
• Rep. Knight, Stephen [R-CA-25] · R · Cosponsor
• Rep. Connolly, Gerald E. [D-VA-11] · D · Cosponsor
• · hsju00 · Standing
• · hsif00 · Standing

Related records

• related to → Prescription Drug Monitoring Act of 2017